Psychiatric Adverse Reactions with Statins, Fibrates and Ezetimibe
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 30 (3) , 195-201
- https://doi.org/10.2165/00002018-200730030-00003
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmissionPsychiatry Research, 2005
- Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adultsThe American Journal of Medicine, 2004
- Severe irritability associated with statin cholesterol-lowering drugsQJM: An International Journal of Medicine, 2004
- Conceptual Foundations of the UCSD Statin StudyArchives of internal medicine (1960), 2004
- Safety Profiles for the HMG-CoA Reductase InhibitorsDrugs, 2001
- The Association of Low Serum Cholesterol with Depression and Suicidal Behaviours: New Hypotheses for the Missing LinkJournal of International Medical Research, 2000
- Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/The American Journal of Medicine, 2000
- Cholesterol and Violence: Is There a Connection?Annals of Internal Medicine, 1998
- Effect of HMGcoA Reductase Inhibitors on StrokeAnnals of Internal Medicine, 1998
- Low serum cholesterol and suicideThe Lancet, 1992